INTERCEPT PHARMACEUTICALS, INC.·4

Jan 9, 8:00 PM ET

Bright Lisa 4

4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Jan 9, 2019

Insider Transaction Report

Form 4
Period: 2019-01-07
Bright Lisa
CCO & Corp Affairs Officer
Transactions
  • Sale

    Common Stock

    2019-01-07$104.93/sh1,313$137,77318,807 total
Footnotes (1)
  • [F1]This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.

Documents

1 file
  • 4
    tv510642_4.xmlPrimary

    OWNERSHIP DOCUMENT